AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 146 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $20,734,000 | +85.8% | 1,526,790 | +3.7% | 0.02% | +58.3% |
| Q1 2020 | $11,161,000 | +7.5% | 1,472,436 | -10.1% | 0.01% | +33.3% |
| Q4 2019 | $10,379,000 | +109.0% | 1,637,081 | +29.2% | 0.01% | +125.0% |
| Q3 2019 | $4,966,000 | -26.1% | 1,266,779 | -8.8% | 0.00% | -33.3% |
| Q2 2019 | $6,720,000 | -34.7% | 1,388,328 | +10.4% | 0.01% | -33.3% |
| Q1 2019 | $10,298,000 | +53.2% | 1,257,336 | +3.4% | 0.01% | +28.6% |
| Q4 2018 | $6,724,000 | -25.1% | 1,215,886 | +19.6% | 0.01% | -12.5% |
| Q3 2018 | $8,976,000 | +897500.0% | 1,016,526 | +787904.7% | 0.01% | – |
| Q2 2018 | $1,000 | – | 129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |